CN102558279B - 熊果酸-3’-取代丙醇酯衍生物的合成及抗肿瘤活性研究 - Google Patents
熊果酸-3’-取代丙醇酯衍生物的合成及抗肿瘤活性研究 Download PDFInfo
- Publication number
- CN102558279B CN102558279B CN201110351089.2A CN201110351089A CN102558279B CN 102558279 B CN102558279 B CN 102558279B CN 201110351089 A CN201110351089 A CN 201110351089A CN 102558279 B CN102558279 B CN 102558279B
- Authority
- CN
- China
- Prior art keywords
- ursolic acid
- propyl alcohol
- alcohol ester
- reaction
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110351089.2A CN102558279B (zh) | 2011-11-09 | 2011-11-09 | 熊果酸-3’-取代丙醇酯衍生物的合成及抗肿瘤活性研究 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110351089.2A CN102558279B (zh) | 2011-11-09 | 2011-11-09 | 熊果酸-3’-取代丙醇酯衍生物的合成及抗肿瘤活性研究 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102558279A CN102558279A (zh) | 2012-07-11 |
CN102558279B true CN102558279B (zh) | 2014-09-17 |
Family
ID=46405013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110351089.2A Active CN102558279B (zh) | 2011-11-09 | 2011-11-09 | 熊果酸-3’-取代丙醇酯衍生物的合成及抗肿瘤活性研究 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102558279B (zh) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104684883A (zh) * | 2012-08-14 | 2015-06-03 | 内克索利戈有限公司 | 新型乌索酸衍生物及其制备方法 |
CN102875632A (zh) * | 2012-10-18 | 2013-01-16 | 贵州大学 | 熊果酸酯类衍生物及其制备方法及应用 |
CN102875633A (zh) * | 2012-10-22 | 2013-01-16 | 贵州大学 | 桦木酮酸酯类衍生物及其制备方法和用途 |
CN102924558A (zh) * | 2012-10-23 | 2013-02-13 | 贵州大学 | 桦木酸酯类衍生物及其制备方法和用途 |
CN104672294B (zh) * | 2015-02-12 | 2017-01-25 | 广东药学院 | 化合物3‑o‑(2‑(5‑氟尿嘧啶‑1‑)乙酰)‑熊果酸甲酯的合成及其作为抗肿瘤药物的应用 |
CN104744548B (zh) * | 2015-02-12 | 2016-11-09 | 广东药学院 | 化合物3-o-(2-(5-氟尿嘧啶-1-)乙酰)-熊果酸的合成及其作为抗肿瘤药物的应用 |
CN106946972B (zh) * | 2017-05-16 | 2019-04-19 | 烟台大学 | 一种具有抗肿瘤活性的熊果酸衍生物及其制备方法 |
CN107033212B (zh) * | 2017-05-16 | 2019-07-30 | 烟台大学 | 一种具有抗炎活性的熊果酸衍生物及其制备方法和用途 |
CN107129518A (zh) * | 2017-06-08 | 2017-09-05 | 延边大学 | 一类含氮杂环结构的三萜皂苷类衍生物及其合成方法和应用 |
CN108558986B (zh) * | 2018-05-29 | 2021-03-05 | 亿利耐雀生物科技有限公司 | 含哌嗪结构的甘草次酸类衍生物及其制备方法与用途 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101182345A (zh) * | 2007-12-14 | 2008-05-21 | 四川国康药业有限公司 | 一类具有抗炎活性的熊果酸噁唑啉类新药及其制备方法 |
CN101792477A (zh) * | 2010-03-02 | 2010-08-04 | 福州大学 | 具抗癌活性的乙酰熊果酰三乙醇胺单酯及其制备方法 |
CN101928322A (zh) * | 2010-03-02 | 2010-12-29 | 福州大学 | 具抗癌活性的熊果酸修饰物多元醇单酯 |
-
2011
- 2011-11-09 CN CN201110351089.2A patent/CN102558279B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101182345A (zh) * | 2007-12-14 | 2008-05-21 | 四川国康药业有限公司 | 一类具有抗炎活性的熊果酸噁唑啉类新药及其制备方法 |
CN101792477A (zh) * | 2010-03-02 | 2010-08-04 | 福州大学 | 具抗癌活性的乙酰熊果酰三乙醇胺单酯及其制备方法 |
CN101928322A (zh) * | 2010-03-02 | 2010-12-29 | 福州大学 | 具抗癌活性的熊果酸修饰物多元醇单酯 |
Also Published As
Publication number | Publication date |
---|---|
CN102558279A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102558279B (zh) | 熊果酸-3’-取代丙醇酯衍生物的合成及抗肿瘤活性研究 | |
Zhang et al. | Design, synthesis and biological evaluation of novel furoxan-based coumarin derivatives as antitumor agents | |
Sun et al. | Three new cytotoxic aryltetralin lignans from Sinopodophyllum emodi | |
Kakumu et al. | Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis | |
He et al. | Synthesis and biological evaluation of novel derivatives of gambogic acid as anti-hepatocellular carcinoma agents | |
JP2009280610A (ja) | 腫瘍/癌細胞の増殖の抑制活性を有するガンボージ樹脂から単離した化合物及びその化合物を含む薬学的組成物 | |
CN106632383B (zh) | 莪术醇衍生物及其制备方法和在抗肿瘤药物中的应用 | |
CN109939091A (zh) | 化合物在制备用于治疗结肠直肠癌的药物中的用途 | |
CN104387389A (zh) | 1,2,3-***-黄酮类化合物-苦参碱三元轭联物和用途 | |
Qi et al. | Novel triazole analogs of apigenin‑7‑methyl ether exhibit potent antitumor activity against ovarian carcinoma cells via the induction of mitochondrial‑mediated apoptosis | |
CN104151391B (zh) | 一种具有抗肿瘤作用的齐墩果酸衍生物及其制备方法和用途 | |
CN104523664A (zh) | 姜黄素类抗肿瘤药物及其应用 | |
Zaim et al. | Novel synthesis naringenin-benzyl piperazine derivatives prevent glioblastoma invasion by inhibiting the hypoxia-induced IL6/JAK2/STAT3 axis and activating caspase-dependent apoptosis | |
Lv et al. | Synthesis, biological evaluation of chrysin derivatives as potential immunosuppressive agents | |
WO2011131102A1 (zh) | 含笑内酯的制备方法及其用途 | |
CN101152192A (zh) | 1,3-二-O-没食子酰基1-4,6-(S)-HHDP-β-D-吡喃葡萄糖在制备抗肿瘤药物中的应用 | |
CN102731454A (zh) | 去氢木香烃内酯衍生物,其药物组合物及其制备方法和用途 | |
CN101152193B (zh) | 1,3,4-三-O-没食子酰基-6-O-咖啡酰基-β-D-吡喃葡萄糖在制备抗肿瘤药物中的应用 | |
CN103012394B (zh) | 一种罗丹宁衍生物及其制备方法 | |
CN101569654A (zh) | 木豆叶超临界提取物及木豆芪酸在制备抗肿瘤药物中的应用 | |
CN106946974B (zh) | 一类含吡唑杂环的熊果酰胺衍生物及其合成与应用 | |
CN105418597B (zh) | 1,3-二羟基呫吨酮衍生物及其在医药中的用途 | |
CN104341407A (zh) | 喹唑啉类化合物及其制备方法和用途 | |
CN104250250A (zh) | 4-芳香胺基嘧啶类化合物及其抗肿瘤用途 | |
CN102850203B (zh) | 一种胡桃醌衍生物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Synthesis and anti-tumor activity research of ursolic acid-3'-substituted propanol ester derivatives Effective date of registration: 20181016 Granted publication date: 20140917 Pledgee: Luzhou Talents Innovation and entrepreneurship equity investment fund partnership (L.P.) Pledgor: SICHUAN GUOKANG PHARMACEUTICAL Co.,Ltd. Registration number: 2018510000103 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230525 Granted publication date: 20140917 Pledgee: Luzhou Talents Innovation and entrepreneurship equity investment fund partnership (L.P.) Pledgor: SICHUAN GUOKANG PHARMACEUTICAL Co.,Ltd. Registration number: 2018510000103 |